David Yadin

David Yadin has a diverse work experience in the field of biotechnology and regenerative therapies. David is currently working as a Principal Scientist at Alchemab Therapeutics Ltd since January 2023. Prior to that, they served as a Senior Scientist at the same company from May 2021 to December 2022. Before joining Alchemab Therapeutics, David worked as a Research Scientist 2 at Kymab Ltd from July 2018 to May 2021. David also gained experience at Crescendo Biologics Limited, where they held roles as a Senior Scientist I from March 2018 to July 2018, and as a Research Scientist from February 2017 to February 2018. David started their career as a Postdoctoral Fellow at the Berlin-Brandenburg School for Regenerative Therapies from November 2013 to January 2017. David also worked as a Post-doctoral research associate at the Department of Biochemistry, University of Oxford, UK from November 2012 to April 2013.

David Yadin attended the University of Oxford from 2004 to 2008, where they earned an MBiochem degree in Biochemistry. David then pursued further studies at the University of Oxford from 2008 to 2012, completing a D.Phil degree in Biochemistry.